tetano
Editor, Senior Moderator
Clin Exp Dermatol
. 2021 Nov 3.
doi: 10.1111/ced.15002. Online ahead of print.
Erythema annulare centrifugum induced by SARS-CoV-2 vaccination
J C Kim[SUP] 1 [/SUP], S Y Lee[SUP] 1 [/SUP], S Y Kang[SUP] 1 [/SUP], H O Kim[SUP] 1 [/SUP], C W Park[SUP] 1 [/SUP], B Y Chung[SUP] 1 [/SUP]
Affiliations
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has become an international pandemic with significant social, health, and economic consequences.[SUP]1[/SUP] To acquire immunityin South Korea, the mRNA vaccines and the viral vector vaccines AZD1222 (Oxford-AstraZeneca COVID-19) and Ad26.COV2.S have been approved as vaccines against SARS-CoV-2.[SUP]2[/SUP] With the rapid rollout of vaccinations, unexpected reactions, including skin reactions, are emerging. We report a case of erythema annulare centrifugum (EAC) after AZD1222 vaccine administration in a patient.
. 2021 Nov 3.
doi: 10.1111/ced.15002. Online ahead of print.
Erythema annulare centrifugum induced by SARS-CoV-2 vaccination
J C Kim[SUP] 1 [/SUP], S Y Lee[SUP] 1 [/SUP], S Y Kang[SUP] 1 [/SUP], H O Kim[SUP] 1 [/SUP], C W Park[SUP] 1 [/SUP], B Y Chung[SUP] 1 [/SUP]
Affiliations
- PMID: 34731529
- DOI: 10.1111/ced.15002
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has become an international pandemic with significant social, health, and economic consequences.[SUP]1[/SUP] To acquire immunityin South Korea, the mRNA vaccines and the viral vector vaccines AZD1222 (Oxford-AstraZeneca COVID-19) and Ad26.COV2.S have been approved as vaccines against SARS-CoV-2.[SUP]2[/SUP] With the rapid rollout of vaccinations, unexpected reactions, including skin reactions, are emerging. We report a case of erythema annulare centrifugum (EAC) after AZD1222 vaccine administration in a patient.